Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats

被引:38
作者
Bengtsson, Christoffer [1 ]
Blaho, Stefan [1 ]
Saitton, David Blomberg [1 ]
Brickmann, Kay [1 ]
Broddefalk, Johan [1 ]
Davidsson, Ojvind [1 ]
Drmota, Tomas [1 ]
Folmer, Rutger [1 ]
Hallberg, Kenth [1 ]
Hallen, Stefan [1 ]
Hovland, Ragnar [1 ]
Isin, Emre [1 ]
Johannesson, Petra [1 ]
Kull, Bengt [1 ]
Larsson, Lars-Olof [1 ]
Lofgren, Lars [1 ]
Nilsson, Kristina E. [1 ]
Noeske, Tobias [1 ]
Oakes, Nick [1 ]
Plowright, Alleyn T. [1 ]
Schnecke, Volker [1 ]
Stahlberg, Pernilla [1 ]
Sorme, Pernilla [1 ]
Wan, Hong [1 ]
Wellner, Eric [1 ]
Oster, Linda [1 ]
机构
[1] AstraZeneca Res & Dev, S-43183 Molndal, Sweden
关键词
Acetyl-CoA carboxylase; Malonyl-CoA; Ligand lipophilicity efficiency; Quinoline; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; DRUG DISCOVERY; MUTANT MICE; COENZYME; DENSITY; DERIVATIVES; ABSORPTION; KNOCKOUT; TISSUE;
D O I
10.1016/j.bmc.2011.04.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of acetyl-CoA carboxylases has the potential for modulating long chain fatty acid biosynthesis and mitochondrial fatty acid oxidation. Hybridization of weak inhibitors of ACC2 provided a novel, moderately potent but lipophilic series. Optimization led to compounds 33 and 37, which exhibit potent inhibition of human ACC2, 10-fold selectivity over inhibition of human ACC1, good physical and in vitro ADME properties and good bioavailability. X-ray crystallography has shown this series binding in the CT-domain of ACC2 and revealed two key hydrogen bonding interactions. Both 33 and 37 lower levels of hepatic malonyl-CoA in vivo in obese Zucker rats. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3039 / 3053
页数:15
相关论文
共 38 条
[1]   Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Kordari, P ;
Oh, W ;
Shaikenov, T ;
Gu, ZW ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (34) :12011-12016
[2]   Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets [J].
Abu-Elheiga, L ;
Oh, WK ;
Kordari, P ;
Wakil, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10207-10212
[3]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[4]  
AbuElheiga L, 1997, J BIOL CHEM, V272, P10669
[5]   Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance [J].
An, J ;
Muoio, DM ;
Shiota, M ;
Fujimoto, Y ;
Cline, GW ;
Shulman, GI ;
Koves, TR ;
Stevens, R ;
Millington, D ;
Newgard, CB .
NATURE MEDICINE, 2004, 10 (03) :268-274
[6]   TERT-BUTYLOXYCARBONYLAMINO ACIDS AND THEIR USE IN PEPTIDE SYNTHESIS [J].
ANDERSON, GW ;
MCGREGOR, AC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (23) :6180-6183
[7]  
[Anonymous], DAT WAS OBT WHO
[8]   DENSITY-FUNCTIONAL THERMOCHEMISTRY .3. THE ROLE OF EXACT EXCHANGE [J].
BECKE, AD .
JOURNAL OF CHEMICAL PHYSICS, 1993, 98 (07) :5648-5652
[9]   Correlation of plasma clearance of 54 extensively metabolized drugs between humans and rats: Mean allometric coefficient of 0.66 [J].
Chiou, WL ;
Robbie, G ;
Chung, SM ;
Wu, TC ;
Ma, C .
PHARMACEUTICAL RESEARCH, 1998, 15 (09) :1474-1479
[10]   Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors [J].
Chonan, Tomomichi ;
Tanaka, Hiroaki ;
Yamamoto, Daisuke ;
Yashiro, Miyoko ;
Oi, Takahiro ;
Wakasugi, Daisuke ;
Ohoka-Sugita, Ayumi ;
Io, Fusayo ;
Koretsune, Hiroko ;
Hiratate, Akira .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (13) :3965-3968